Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL).

Jung, Sung-Hoon

Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL). [electronic resource] - European journal of haematology Jun 2015 - 504-10 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1600-0609

10.1111/ejh.12459 doi


Age Factors
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--adverse effects
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Consolidation Chemotherapy
Cyclophosphamide--adverse effects
Doxorubicin--adverse effects
Drug Administration Schedule
Female
Humans
Induction Chemotherapy
Lymphoma, Large B-Cell, Diffuse--diagnosis
Male
Neoplasm Staging
Prednisone--adverse effects
Rituximab--administration & dosage
Treatment Outcome
Vincristine--adverse effects